Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bisoprololo

Sequacor, Cardicor, Congescor e altri

Bibliografia - Quali fonti bibliografiche per Bisoprololo?

  1. Agenzia Italiana del Farmaco – AIFA, Bisoprololo AHCL – Riassunto Caratteristiche di Prodotto, 2019, 11 ottobre https://farmaci.agenziafarmaco.gov.it/bancadatifarmaci/home (accesso: febbraio 2024).

  2. Ageev F.T. et al., Kardiologia, 2010, 50 (10), 22.

  3. Ågesen F.N. et al., Pharmacol. Res. Perspect., 2019, 7 (4), e00496.

  4. Amaro-Alvarez L. et al., Farm. Hosp., 2024, 9, S1130.

  5. Baker J.G., Br. J. Phrmacol., 2005, 144 (3), 317.

  6. Bennet M.R. et al., Respirology, 2021, 26 (3), 225.

  7. Bhalla H. et al., Curr. Drug Saf., 2021, 16 (3), 293.

  8. Circulation, 1994, 90 (4), 1765.

  9. Czuriga I. et al., Cardiovasc. Drugs Ther., 2003, 17 (3), 257.

  10. Nehaj F. et al., Am. J. Ther., 2020, 27 (2), e159.

  11. De-Haan T. et al., Neurotoxicol. Teratol., 2023, 98, doi:10.1016/j.ntt.2023.107232

  12. Duke M.E. et al., J. Endocr. Soc., 2019, 3 (5), 973.

  13. Dutta A. et al., J. Clin. Pharmacol., 1994, 34 (8), 829.

  14. Fazio G. et al., Ann. Noninvasive Electrocardiol., 2013, 18 (5), 467.

  15. Feng Z. et al., Int. J. Chron. Obstruct. Pulmon. Dis., 2023, 18, 3067.

  16. Foch C. et al. J. Comp. Eff. Res., 2022, 11 (6), 423.

  17. GINA, Global Initative for Asthma, Updated 2019, https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf (accesso: marzo 2024).

  18. Grevel J. et al., Clin. Pharmacokinet., 1989, 17 (1), 53.

  19. Hayes P.C. et al., Eur. Heart J., 1987, Suppl. M, 23.

  20. Harrington J., Respirology, 2021, 26 (3), 216.

  21. Heindenreich P.A. et al., Circulation, 2022, 145 (18), e895.

  22. Hoeltzenbein M. et al., J. Hypertens., 2018, 36 (10), 2109.

  23. Horikiri et al., J. Pharm. Sci., 1998, 87 (3), 289.

  24. Huang K-Y. et al., Sci. Rep., 2021, 11, 452.

  25. Iribarren C. et al., Am. J. Epidemiol., 2012, 176 (11), 1014.

  26. J. Allergy Clin. Immunol., 2007, 12 (5 Suppl.), S94.

  27. Ichinose M et al., Allergol. Int., 2017, 66 (2), 163.

  28. Ishida K. et al., Drug Metab. Pharmacokinet., 2013, 28 (6), 491.

  29. Kaddoura R. et al., Curr. Probl. Cardiol., 2024, 49 (3), 102376.

  30. Kayser A. et al., J. Hypertens., 2020, 38 (2), 354.

  31. Kirch W. et al., Eur. J. Clin. Pharmacol., 1986, 31 (1), 59

  32. Kirch W. et al., Clin. Pharmacokin., 1987, 13 (2), 110.

  33. Kramer B. et al., J. Cardiovascul. Pharmacol., 1986, 8 Suppl. 11, S46

  34. Lacmed, 2023, 15 August https://www.ncbi.nlm.nih.gov/books/NBK501144/ (accesso: febbraio, 2024).

  35. Lancaster S.G.,Sorkin E. M., Drugs, 1988, 36, 256.

  36. Lancet, 1999, 353 (9146), 9.

  37. Leopold G. et al., Br. J. Clin. Pharmacol., 1986, 22, 293.

  38. Létinier L. et al., Front. Pharmacol., 2019, 10, 265.

  39. Lista WADA, 2024 https://www.nadoitalia.it/images/lista-wada/2024list_en_final_22_september_2023.pdf (accesso: febbraio 2024).

  40. Liu J. et al., Expert. Opin. Drug Metab. Toxicol., 2019, 15 (9), 687.

  41. Matsouka H. et al., J. Clin. Hypertens., 2013, 15 (11), 806.

  42. Momomura S.I. et al., Circ. J., 2017, 82 (1), 141.

  43. Morales D.R. et al., Chest., 2014, 145 (4), 779.

  44. Morales D.R. et al., BMC Medicine, 2017, 15 (1), 18.

  45. Muresan L. et al., Ann. Pharm. Fr., 2022, 80 (5), 617.

  46. NACAN, Australian Asthma Handbook, 2019 https://www.asthmahandbook.org.au/static/files/Australian-Asthma-Handbook-v2.0-Management-%E2%80%93-Adults.pdf (accesso: marzo 2024).

  47. Nehaj F. et al., Am. J. Ther., 2020, 27 (2), e159.

  48. Salpeter S. et al., Cochrane Database Syst. Rev., 2002, 4, CD002992.

  49. SIGNS, British Guideline on the Management of Asthma, SIGN 158, 2019 https://www.sign.ac.uk/media/1773/sign158-updated.pdf (accesso: marzo 2024).

  50. Payton C.D. et al., Eur. Heart J., 1987, 8 Suppl. M, 15.

  51. Ponikowski P. et al., Eur. Heart J., 2016, 37 (27), 2129.

  52. Tanaka K. et al., Circ. J., 2016, 80 (10), 2221.

  53. Toa Eito, Bisono Tale (TY-0201), 2023, https://www.toaeiyo.co.jp/english/partnerships/licensing/bisono-tape.html (accesso: marzo 2024).

  54. Tiotiu A.et al., Expert. Rev. Respir. Med., 2019, 13 (9), 815.

  55. Verrostte J.M. et al., J. Cardiovasc. Pharmacol., 1990, 16 Suppl. 5, S193.

  56. Wezel T. et al., Neonatology, 2021, 118 (4), 406.

  57. Warrington S.J. et al., J. Cardiovasc. Pharmacol., 1990, 16 Suppl. 5, S164.

  58. Willenheimer R. et al., Circulation, 2005, 112 (16), 2426.

  59. Yamashita T. et al., J. Cardiol., 2019, 73 (5), 386.